Logo image of LITS

LITE STRATEGY INC (LITS) Stock Overview

USA - NASDAQ:LITS - US55279B3015 - Common Stock

2.45 USD
-0.15 (-5.77%)
Last: 10/7/2025, 8:00:02 PM
2.51 USD
+0.06 (+2.45%)
Pre-Market: 10/8/2025, 5:23:19 AM

LITS Key Statistics, Chart & Performance

Key Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap87.37M
Shares35.66M
Float29.21M
Yearly Dividend1.75
Dividend YieldN/A
EPS(TTM)2.67
PE0.92
Fwd PEN/A
Earnings (Next)11-10 2025-11-10
IPO12-18 2003-12-18
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


LITS short term performance overview.The bars show the price performance of LITS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -2 -4 -6

LITS long term performance overview.The bars show the price performance of LITS in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of LITS is 2.45 USD.

LITE STRATEGY INC / LITS Daily stock chart

LITS Latest News, Press Relases and Analysis

LITS Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 21.99 411.31B
AMGN AMGEN INC 13.55 159.11B
GILD GILEAD SCIENCES INC 15.09 144.90B
VRTX VERTEX PHARMACEUTICALS INC 24.22 105.19B
REGN REGENERON PHARMACEUTICALS 12.78 61.82B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 60.24B
ARGX ARGENX SE - ADR 86.01 48.80B
ONC BEONE MEDICINES LTD-ADR 5.52 37.52B
INSM INSMED INC N/A 34.31B
BNTX BIONTECH SE-ADR N/A 25.50B
NTRA NATERA INC N/A 23.13B
BIIB BIOGEN INC 9.51 22.32B

About LITS

Company Profile

LITS logo image MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. The company is headquartered in San Diego, California and currently employs 28 full-time employees. The company went IPO on 2003-12-18. The firm's treasury initiative is anchored by Litecoin. The firm has discontinued the clinical development of voruciclib, while certain nonclinical activities related to its drug candidate assets continue to be conducted by it. As part of the review of strategic alternatives, the Company may consider options such as out-licensing opportunities for existing programs and merger and acquisition opportunities.

Company Info

LITE STRATEGY INC

9920 Pacific Heights Blvd, Suite 150

San Diego CALIFORNIA US

Employees: 28

LITS Company Website

LITS Investor Relations

Phone: 18583697100

LITE STRATEGY INC / LITS FAQ

What is the stock price of LITE STRATEGY INC today?

The current stock price of LITS is 2.45 USD. The price decreased by -5.77% in the last trading session.


What is the ticker symbol for LITE STRATEGY INC stock?

The exchange symbol of LITE STRATEGY INC is LITS and it is listed on the Nasdaq exchange.


On which exchange is LITS stock listed?

LITS stock is listed on the Nasdaq exchange.


What is LITE STRATEGY INC worth?

LITE STRATEGY INC (LITS) has a market capitalization of 87.37M USD. This makes LITS a Micro Cap stock.


How many employees does LITE STRATEGY INC have?

LITE STRATEGY INC (LITS) currently has 28 employees.


What are the support and resistance levels for LITE STRATEGY INC (LITS) stock?

LITE STRATEGY INC (LITS) has a resistance level at 2.69. Check the full technical report for a detailed analysis of LITS support and resistance levels.


Is LITE STRATEGY INC (LITS) expected to grow?

The Revenue of LITE STRATEGY INC (LITS) is expected to decline by -100% in the next year. Check the estimates tab for more information on the LITS EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy LITE STRATEGY INC (LITS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does LITE STRATEGY INC (LITS) stock pay dividends?

LITS does not pay a dividend.


When does LITE STRATEGY INC (LITS) report earnings?

LITE STRATEGY INC (LITS) will report earnings on 2025-11-10.


What is the Price/Earnings (PE) ratio of LITE STRATEGY INC (LITS)?

The PE ratio for LITE STRATEGY INC (LITS) is 0.92. This is based on the reported non-GAAP earnings per share of 2.67 and the current share price of 2.45 USD. Check the full fundamental report for a full analysis of the valuation metrics for LITS.


What is the Short Interest ratio of LITE STRATEGY INC (LITS) stock?

The outstanding short interest for LITE STRATEGY INC (LITS) is 6.29% of its float. Check the ownership tab for more information on the LITS short interest.


LITS Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to LITS.


Chartmill TA Rating
Chartmill Setup Rating

LITS Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to LITS. While LITS has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LITS Financial Highlights

Over the last trailing twelve months LITS reported a non-GAAP Earnings per Share(EPS) of 2.67. The EPS increased by 157.67% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -152.38%
ROE -162.03%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%71.81%
Sales Q2Q%N/A
EPS 1Y (TTM)157.67%
Revenue 1Y (TTM)-100%

LITS Forecast & Estimates

For the next year, analysts expect an EPS growth of -339.91% and a revenue growth -100% for LITS


Analysts
Analysts43.33
Price TargetN/A
EPS Next Y-339.91%
Revenue Next Year-100%

LITS Ownership

Ownership
Inst Owners8.13%
Ins Owners14.43%
Short Float %6.29%
Short Ratio0.82